TAK-721

Health

adminDecember 9, 2020
6

Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

Osaka, Japan: Company Aiming for Mid-Single-Digit Revenue CAGR Over Next Decade Amounting to JPY5 Trillion ($47 Billion) by FY20301 Wave…
Read More »
Business

adminOctober 29, 2020
6

Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year Management Guidance & Raises Forecasts for Free Cash Flow, Reported OP & Reported EPS

Osaka, Japan: FY2020 H1 results driven by growth of global brands (e.g. Entyvio +25.8% YOY, TAKHZYRO +45.5% YOY, NINLARO +…
Read More »